Bill Text: IL HB0033 | 2021-2022 | 102nd General Assembly | Chaptered

---

Bill Title: Amends the Illinois Insurance Code. Provides that a company authorized to transact life insurance in the State may not, based solely on whether an individual has participated in a substance use treatment or recovery support program no less than 5 years before application or whether an individual has been prescribed or has obtained through a standing order an opioid antagonist, deny coverage to an individual; limit the amount, extent, or kind of coverage available to the individual; or charge the individual or a group to which the individual belongs a rate that is different from the rate charged to other individuals or groups for the same coverage unless the charge is based on sound underwriting or actuarial principles reasonably related to actual or anticipated loss experience for a particular risk.

Spectrum: Partisan Bill (Democrat 11-0)

Status: (Passed) 2021-07-23 - Public Act . . . . . . . . . 102-0107 [HB0033 Detail]

Download: Illinois-2021-HB0033-Chaptered.html

---

Public Act 102-0107
HB0033 Enrolled LRB102 04106 BMS 14123 b
AN ACT concerning regulation.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
Section 5. The Illinois Insurance Code is amended by
adding Sections 155.47 and 155.48 as follows:
(215 ILCS 5/155.47 new)
Sec. 155.47. Prohibited practices relating to substance
use disorder treatment.
(a) As used in this Section, "recovery support",
"substance use disorder", and "treatment" have the meanings
set forth in the Substance Use Disorder Act.
(b) A company authorized to transact life insurance in
this State may not, based solely on whether an individual has
participated in a substance use treatment or recovery support
program no less than 5 years before application:
(1) deny coverage to the individual;
(2) limit the amount, extent, or kind of coverage
available to the individual; or
(3) charge the individual or a group to which the
individual belongs a rate that is different from the rate
charged to other individuals or groups, respectively, for
the same coverage, unless the charge is based on sound
underwriting or actuarial principles reasonably related to

actual or anticipated loss experience for a particular
risk.
(215 ILCS 5/155.48 new)
Sec. 155.48. Prohibited practices relating to prescription
for or obtainment of opioid antagonist.
(a) As used in this Section, "opioid antagonist" means any
drug that binds to opioid receptors and blocks or otherwise
inhibits the effects of opioids acting on those receptors to
reverse the effects of an opioid overdose.
(b) A company authorized to transact life insurance in
this State may not, based solely on whether an individual has
been prescribed or has obtained through a standing order an
opioid antagonist:
(1) deny coverage to the individual;
(2) limit the amount, extent, or kind of coverage
available to the individual; or
(3) charge the individual or a group to which the
individual belongs a rate that is different from the rate
charged to other individuals or groups, respectively, for
the same coverage, unless the charge is based on sound
underwriting or actuarial principles reasonably related to
actual or anticipated loss experience for a particular
risk.